Luke J Laffin

This new data is essentially saying that the decreases in LDL cholesterol and triglycerides we saw at 60 days after treatment have lasted over a year,

• Laffin said
  CNNcnn.com/2026/08…Aug 28, 14:30

This is a really big step for CRISPR to show the durability of the result,

• says Dr. Luke Laffin, co-director of the Center for Blood Pressure Disorders at the Cleveland Clinic and lead author of the study
  Timetime.com/article/2026…Aug 28, 00:00

We could look at a situation further down the line where we are able to give people a choice,

• says Laffin
  Timetime.com/article/2026…Aug 28, 00:00

Is something like this truly a one and done? That was always the question,

• said lead study author Dr. Luke Laffin, a preventive cardiologist at Cleveland Clinic’s Heart, Vascular & Thoracic Institute
  CNNcnn.com/2026/08…Aug 28, 14:30

One of the amazing results of the study has been the public response asking if they can be involved with these clinical trials,

• Laffin said
  CNNcnn.com/2026/08…Aug 28, 14:30

As a preventive cardiologist, you’re really thinking, I’ll treat people chronically for many, many years,

• said Dr. Luke Laffin, a cardiologist at the Cleveland Clinic who led the new study
  The New York Timesnytimes.com/2026/08…Aug 28, 14:30